The operation, which also includes a bank loan, is co-led by Columbus Ventures Partners and Caixa Capital Risc and has had the participation of Ysios Capital and Fund .
X-linked adrenoleukodystrophy (X-ALD) is a rare, neurodegenerative and hereditary disease that affects some 20,000 citizens in Europe and for which there is no treatment. The most common form is adrenomyeloneuropathy (AMN).
